Market Research Logo

Global CAR T Cell Therapy Market, By Targeted Antigen, Therapeutic Application, and Geography - Trends, Analysis and Forecast till 2028

Global CAR T Cell Therapy Market, By Targeted Antigen, Therapeutic Application, and Geography - Trends, Analysis and Forecast till 2028

Report Description
CAR-T cell therapy is a novel immunotherapy that helps to treat various types of cancers. CAR-T cells are genetically engineered cell receptors that are attached to the T-cells of the cancer patients and infused through the blood stream that activates immune system to kill the cancer causing cells in the body. The T-cells injected into the patient’s body aids in reducing the risk of recurrence of tumor and thus, acts as a cure treatment for patients suffering with blood cancer. The CAR-T cell therapy is a solution to overcome the disease progression, identify the cancer causing cells, and kill them using body’s own immune system and defense mechanism.
Market Dynamics
CAR-T cell therapy is expected to be an important development in cancer treatment and therapeutics industry due to its cost efficiency. Moreover, rising incidence of cancer is leading to high demand for its treatment. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were reported worldwide, in 2012. As per WCRFI, it is projected that by 2035, around 24 million cancer cases would be observed worldwide. Moreover, introduction of new therapies into the market is further expected to bolster growth of CAR-T cell therapy market. For instance, in October 2017, the U.S. Food and Drug Administration granted marketing approval to Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma. However, risks of side effects resulting in various neurological disorders is expected to hinder growth of the global CAR-T cell therapy market.
Key features of the study:

  • This report provides in-depth analysis of CAR-T cell therapy market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2017 – 2028), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global CAR-T cell therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study includes Novartis International AG, Kite Pharma, Inc., Juno Therapeutics, Pfizer, Inc., Bellicum Pharmaceuticals, Inc., Celgene Corporation, Cellectis, and others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing strategies
  • The global CAR-T cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the CAR-T cell therapy market
Detailed Segmentation:
  • Global CAR-T Cell Therapy Market, by Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • Global CAR-T Cell Therapy Market, by Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • Global CAR-T Cell Therapy Market, by Region:
  • North America
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Targeted Antigen:
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
  • Others
  • By Therapeutic Application:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Others
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Novartis International AG *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Kite Pharma, Inc.
  • Juno Therapeutics
  • Pfizer, Inc.
  • Bellicum Pharmaceuticals, Inc.
  • Celgene Corporation
  • Cellectis
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Targeted Antigen
Market Snippet By Therapeutic Application
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trend
Epidemiology/Prevalence/Incidence
Merger and Acquisitions
New Product Approvals/Launch
4. Global Car T Cell Therapy Market, By Targeted Antigen, 2017 - 2028 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2028 (%)
Y-O-Y Growth Analysis, 2017 - 2028
Segment Trends
CD 19
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
CD 20
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
GD2
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
CD22
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
CD30
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
CD33
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
HER1
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
HER2
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Meso
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
EGFRvlll
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
5. Global Car T Cell Therapy Market, By Therapeutic Application, 2017 - 2028 (USD Million)
Introduction
Market Share Analysis, 2017 and 2028 (%)
Y-O-Y Growth Analysis, 2017 - 2028
Segment Trends
Acute Lymphocytic Leukemia
Introduction
Market Share Analysis, 2017 and 2028 (%)
Y-O-Y Growth Analysis, 2017 - 2028
Chronic Lymphocytic Leukemia
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Non Hodgkin Leukemia
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Multiple Myeloma
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Pancreatic Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Neuroblasta
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Breast Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Acute Myeloid Leukemia
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Hepatocellular Carcinoma
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
6. Global Car T Cell Therapy Market, By Regions, 2017 - 2028 (US$ Million)
Introduction
Market Share Analysis, By Region, 2017 and 2028 (%)
Y-O-Y Growth Analysis, For Regions, 2017 - 2028
North America
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Europe
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Asia Pacific
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Latin America
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Africa
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
Middle East
Market Share Analysis, By Segments, 2017 and 2028 (%)
Y-O-Y Growth Analysis, By Segments, 2017 - 2028
Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
7. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Novartis International AG
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Kite Pharma Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Juno Therapeutics
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Bellicum Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Celgene Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Cellectis
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Analyst Views
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Car T Cell Therapy Market - Global forecast to 2024”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report